title: Parietaria judaica-specific T-cell clones from atopic patients: heterogeneity in restriction, V beta usage, and cytokine profile.
abstract: The pollen of Parietaria spp. is one of the most clinically relevant sources of allergens in the Mediterranean area. CD4+ T-lymphocyte clones specific for Parietaria allergens were isolated from peripheral blood of atopic donors, and their phenotype, HLA restriction, V beta usage, and cytokine profile were determined. All the T-cell clones expressed the alpha/beta T-cell receptor and were induced to express CD40 ligand after activation with phorbol-myristate-acetate plus ionomycin. When the proliferative response to three chromatographic fractions of the extract was analyzed, distinct reactivity patterns were found. Interestingly, most of the clones responded to the fraction that was the most enriched for the major allergen Par j 1. The clones were either HLA-DR- or HLA-DQ-restricted and did not show any preferential usage of T-cell receptor V beta segments. Five of the 17 clones tested produced only IL-4 and no interferon-gamma, thus displaying a TH2 phenotype. The other clones displayed a TH0 phenotype in that they produced both IL-4 and interferon-gamma. These results show that in atopic patients T-cell response against Parietaria judaica allergen involves different T-cell subsets in terms of restriction, V beta usage, and cytokine profile.
authors.affiliation: Department of Immunology, University of Rome La Sapienza, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Sallusto
authors.forename: S
authors.initials: S
authors.lastname: Corinti
authors.forename: C
authors.initials: C
authors.lastname: Pini
authors.forename: M M
authors.initials: MM
authors.lastname: Biocca
authors.forename: G
authors.initials: G
authors.lastname: Bruno
authors.forename: G
authors.initials: G
authors.lastname: Di Felice
mesh_terms: D000485:Allergens / Q000276:immunology*; D019013:CD40 Antigens / Q000378:metabolism; D002999:Clone Cells; D016207:Cytokines / Q000378:metabolism*; D000939:Epitopes; D006683:HLA-DQ Antigens / Q000032:analysis; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000097:blood* / Q000473:pathology; D015151:Immunoblotting; D007371:Interferon-gamma / Q000378:metabolism; D007376:Interleukin-2 / Q000378:metabolism; D015847:Interleukin-4 / Q000378:metabolism; D008024:Ligands; D008213:Lymphocyte Activation; D011058:Pollen / Q000276:immunology*; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000502:physiology*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000485:Allergens; D019013:CD40 Antigens; D016207:Cytokines; D000939:Epitopes; D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens; D007376:Interleukin-2; D008024:Ligands; D016693:Receptors, Antigen, T-Cell, alpha-beta; D015847:Interleukin-4; D007371:Interferon-gamma